Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Skin Cancer Diagnostics Market, by Type
1.4.2 Europe Skin Cancer Diagnostics Market, by Test Type
1.4.3 Europe Skin Cancer Diagnostics Market, by End-use
1.4.4 Europe Skin Cancer Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Skin Cancer Diagnostics Market by Type
4.1 Europe Non-Melanoma Market by Country
4.2 Europe Melanoma Market by Country
Chapter 5. Europe Skin Cancer Diagnostics Market by Test Type
5.1 Europe Skin Biopsy Market by Country
5.2 Europe Imaging Tests Market by Country
5.3 Europe Dermatoscopy Market by Country
5.4 Europe Lymph Node Biopsy Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Skin Cancer Diagnostics Market by End-use
6.1 Europe Hospital & Clinics Market by Country
6.2 Europe Laboratories Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Skin Cancer Diagnostics Market by Country
7.1 Germany Skin Cancer Diagnostics Market
7.1.1 Germany Skin Cancer Diagnostics Market by Type
7.1.2 Germany Skin Cancer Diagnostics Market by Test Type
7.1.3 Germany Skin Cancer Diagnostics Market by End-use
7.2 UK Skin Cancer Diagnostics Market
7.2.1 UK Skin Cancer Diagnostics Market by Type
7.2.2 UK Skin Cancer Diagnostics Market by Test Type
7.2.3 UK Skin Cancer Diagnostics Market by End-use
7.3 France Skin Cancer Diagnostics Market
7.3.1 France Skin Cancer Diagnostics Market by Type
7.3.2 France Skin Cancer Diagnostics Market by Test Type
7.3.3 France Skin Cancer Diagnostics Market by End-use
7.4 Russia Skin Cancer Diagnostics Market
7.4.1 Russia Skin Cancer Diagnostics Market by Type
7.4.2 Russia Skin Cancer Diagnostics Market by Test Type
7.4.3 Russia Skin Cancer Diagnostics Market by End-use
7.5 Spain Skin Cancer Diagnostics Market
7.5.1 Spain Skin Cancer Diagnostics Market by Type
7.5.2 Spain Skin Cancer Diagnostics Market by Test Type
7.5.3 Spain Skin Cancer Diagnostics Market by End-use
7.6 Italy Skin Cancer Diagnostics Market
7.6.1 Italy Skin Cancer Diagnostics Market by Type
7.6.2 Italy Skin Cancer Diagnostics Market by Test Type
7.6.3 Italy Skin Cancer Diagnostics Market by End-use
7.7 Rest of Europe Skin Cancer Diagnostics Market
7.7.1 Rest of Europe Skin Cancer Diagnostics Market by Type
7.7.2 Rest of Europe Skin Cancer Diagnostics Market by Test Type
7.7.3 Rest of Europe Skin Cancer Diagnostics Market by End-use
Chapter 8. Company Profiles
8.1 Castle Biosciences, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.1.4.2 Acquisition and Mergers:
8.1.5 SWOT Analysis
8.2 Bausch Health Companies, Inc.(DermTech, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Canfield Scientific, Inc.
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 DermaSensor, Inc.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Neogenomics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Quest Diagnostics Incorporated
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Recent strategies and developments:
8.7.4.1 Partnerships, Collaborations, and Agreements:
8.7.4.2 Acquisition and Mergers:
8.7.5 SWOT Analysis
8.8 Digital Diagnostics, Inc.(3Derm Systems, Inc.)
8.8.1 Company Overview
8.9 FotoFinder Systems GmbH
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. VERISKIN INC.
8.10.1 Company Overview
8.10.2 SWOT Analysis
Unique Offerings 